Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

U.K.’s Fraud Office, China Cooperating in GSK Bribery Investigation

Roberta Holland | July 30, 2014

The increasingly international bribery investigation into British drugmaker GlaxoSmithKline has led to unusual cooperation between U.K. and Chinese anti-fraud officials.

David Green, director of the U.K.’s Serious Fraud Office (SFO), told Reuters in an interview last week that this is the first time he is aware of Chinese officials cooperating in an SFO case.

Both governments are investigating allegations that GSK employees in its China unit bribed doctors with cash and gifts to boost drug sales in the market. Chinese officials have accused the company’s former China head, Mark Reilly, and other GSK employees with a widespread bribery scheme involving as much as 3 billion yuan. The corruption allegations, along with a sex tape of Reilly and his girlfriend...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.